Jamey P. Weichert

Affiliations: 
University of Wisconsin, Madison, Madison, WI 
Area:
Oncology, Medical Biophysics, Radiation Physics
Google:
"Jamey Weichert"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kerr CP, Jin WJ, Liu P, et al. (2024) Priming versus propagating: distinct immune effects of an alpha- versus beta-particle emitting radiopharmaceutical when combined with immune checkpoint inhibition. Biorxiv : the Preprint Server For Biology
Marsh IR, Li C, Grudzinski J, et al. (2023) Targeting of Head and Neck Cancer by Radioiodinated CLR1404 in Murine Xenograft Tumor Models with Partial Volume Corrected Theranostic Dosimetry. Cancer Biotherapy & Radiopharmaceuticals
Pinchuk AN, Rampy MA, Longino MA, et al. (2023) Effect of Polar Head Group Modifications on the Tumor Retention of Phospholipid Ether Analogs: Role of the Quaternary Nitrogen. Pharmaceutics. 15
Zhang RR, Choi C, Brunnquell CL, et al. (2022) Next-Generation Cancer Magnetic Resonance Imaging With Tumor-Targeted Alkylphosphocholine Metal Analogs. Investigative Radiology. 57: 655-663
Patel RB, Hernandez R, Carlson P, et al. (2021) Low-dose targeted radionuclide therapy renders immunologically cold tumors responsive to immune checkpoint blockade. Science Translational Medicine. 13
Carlson PM, Mohan M, Patel RB, et al. (2021) Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. Journal of Immunology (Baltimore, Md. : 1950)
Clark PA, Sriramaneni RN, Bates AM, et al. (2021) Low-Dose Radiation Potentiates the Propagation of Anti-Tumor Immunity against Melanoma Tumor in the Brain after In Situ Vaccination at a Tumor outside the Brain. Radiation Research
Sosa GA, Bates AM, Patel R, et al. (2020) Abstract 903: In vivo efficacy of bempegaldesleukin, immune checkpoint inhibition, and targeted radionuclide therapy in immunocompetent murine model of head and neck cancer Immunology. 80: 903-903
Jagodinsky JC, Arthur IS, Castillo JS, et al. (2020) Abstract 477: Comparing type 1 interferon activation in tumor cells following external beam radiotherapy versus targeted radionuclide therapy Tumor Biology
Hernandez R, Grudzinski JJ, Aluicio-Sarduy E, et al. (2019) Lu-NM600 targeted radionuclide therapy extends survival in syngeneic murine models of triple-negative breast cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
See more...